» Articles » PMID: 17724160

First Report of the Emergence of CTX-M-type Extended-spectrum Beta-lactamases (ESBLs) As the Predominant ESBL Isolated in a U.S. Health Care System

Overview
Specialty Pharmacology
Date 2007 Aug 29
PMID 17724160
Citations 80
Authors
Affiliations
Soon will be listed here.
Abstract

CTX-M-type extended-spectrum beta-lactamases (ESBLs) have become increasingly common worldwide, with the notable exception of the United States, where TEM- and SHV-type ESBLs have appeared to predominate. We have noted the emergence of ESBLs in our health care system (the University Health System in San Antonio, TX), especially in Escherichia coli isolates, that preferentially hydrolyze cefotaxime rather than ceftazidime, suggesting the possibility of CTX-M-type enzymes. Microbiology laboratory records were reviewed to identify ESBL-producing isolates and to compare the diameters of ceftazidime disk diffusion zones of inhibition to cefotaxime zone diameters. All isolates had been initially detected and confirmed using the procedures recommended by the Clinical and Laboratory Standards Institute. A total of 94 stored ESBL-producing isolates recovered between January 2000 and June 2006 (predominately from blood and normally sterile fluids) were retrieved for further study and screened using PCR primers specific for the presence of CTX-M, TEM, and SHV ESBLs. Only small numbers of retained ESBL-producing isolates were available for study in 2000 and 2002. The percentages of available ESBL-producing organisms in the following years were found to produce CTX-M enzymes: 2000, 25%; 2001, 10%; 2002, 0%; 2003, 60%; 2004, 69%; 2005, 89%; and 2006, 70%. The most common CTX-M-type ESBL was CTX-M-15, followed by CTX-M-16, CTX-M-8, and CTX-M-14. Comparing the disk diffusion zone diameters of cefotaxime and ceftazidime was helpful with the initial recognition of CTX-M-producing E. coli, which had an average cefotaxime zone diameter 7 mm smaller than the ceftazidime zone. However, comparing ceftazidime and cefotaxime zones for CTX-M-producing Klebsiella spp. was not helpful with initial recognition. CTX-M enzymes were also identified in Proteus mirabilis, Enterobacter spp., and Morganella morganii. Based on pulsed-field gel electrophoresis typing of the E. coli isolates, the CTX-M-producing isolates did not represent the spread of a single clone in the institution or in the community. In conclusion, CTX-M-type ESBLs are now the most common ESBL type isolated from patients in our health care system and may also be present but unrecognized in other U.S. locales.

Citing Articles

The overlap of accessory virulence factors and multidrug resistance among clinical and surveillance Klebsiella pneumoniae isolates from a neonatal intensive care unit in Nepal: a single-centre experience in a resource-limited setting.

Shrestha R, Shrestha D, Kunwar A, Thapa S, Shrestha N, Dhoubhadel B Trop Med Health. 2024; 52(1):30.

PMID: 38589977 PMC: 11000294. DOI: 10.1186/s41182-024-00595-3.


The causes of bacterial bloodstream infections and antimicrobial resistance patterns in children attending a secondary care hospital in Bhaktapur, Nepal, 2017-2022: a retrospective study.

Shrestha R, Shrestha D, Sah A, Thapa A, Shrestha N, Raya G JAC Antimicrob Resist. 2024; 6(2):dlae035.

PMID: 38476771 PMC: 10928669. DOI: 10.1093/jacamr/dlae035.


Characterization of Transferrable Mechanisms of Quinolone Resistance (TMQR) among Quinolone-resistant Escherichia coli and Klebsiella pneumoniae causing Urinary Tract Infection in Nepalese Children.

Shrestha R, Thapa A, Shrestha D, Pokhrel S, Aryal A, Adhikari R BMC Pediatr. 2023; 23(1):458.

PMID: 37704964 PMC: 10498618. DOI: 10.1186/s12887-023-04279-5.


Detecting genes associated with antimicrobial resistance and pathogen virulence in three New Zealand rivers.

Davis M, Midwinter A, Cosgrove R, Death R PeerJ. 2021; 9:e12440.

PMID: 34950535 PMC: 8647715. DOI: 10.7717/peerj.12440.


Identification of CTX-M Type ESBL from Sheep and Their Abattoir Environment Using Whole-Genome Sequencing.

Atlaw N, Keelara S, Correa M, Foster D, Gebreyes W, Aidara-Kane A Pathogens. 2021; 10(11).

PMID: 34832635 PMC: 8618867. DOI: 10.3390/pathogens10111480.


References
1.
Bonnet R . Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother. 2003; 48(1):1-14. PMC: 310187. DOI: 10.1128/AAC.48.1.1-14.2004. View

2.
Edelstein M, Pimkin M, Palagin I, Edelstein I, Stratchounski L . Prevalence and molecular epidemiology of CTX-M extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Russian hospitals. Antimicrob Agents Chemother. 2003; 47(12):3724-32. PMC: 296190. DOI: 10.1128/AAC.47.12.3724-3732.2003. View

3.
Paterson D, Ko W, von Gottberg A, Mohapatra S, Casellas J, Goossens H . Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases. Clin Infect Dis. 2004; 39(1):31-7. DOI: 10.1086/420816. View

4.
Munday C, Whitehead G, Todd N, Campbell M, Hawkey P . Predominance and genetic diversity of community- and hospital-acquired CTX-M extended-spectrum beta-lactamases in York, UK. J Antimicrob Chemother. 2004; 54(3):628-33. DOI: 10.1093/jac/dkh397. View

5.
Miranda G, Kelly C, Solorzano F, Leanos B, Coria R, Patterson J . Use of pulsed-field gel electrophoresis typing to study an outbreak of infection due to Serratia marcescens in a neonatal intensive care unit. J Clin Microbiol. 1996; 34(12):3138-41. PMC: 229471. DOI: 10.1128/jcm.34.12.3138-3141.1996. View